Press Releases :: OPKO Health, Inc. (OPK)

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

Read the news release

Visit BioReference Health

Year

Category

Dec 3, 2014 8:30 am EST

OPKO Health to Present at the Oppenheimer 25th Annual Healthcare Conference

Nov 13, 2014 9:21 am EST

OPKO Health to Present at the Jefferies 2014 Global Healthcare Conference

Nov 10, 2014 8:37 am EST

OPKO Announces Publication of Large, Prospective, Multi-Institutional Clinical Validation of the 4Kscore™ Test for High Grade Prostate Cancer in the United States

Nov 7, 2014 11:31 am EST

OPKO To Hold Conference Call on November 10, 2014

Nov 7, 2014 8:28 am EST

OPKO Announces Third Quarter Operating and Financial Results

Oct 9, 2014 11:15 am EDT

Neovasc, an OPKO Investee, Receives FDA Conditional Approval to Initiate TIARA-I Trial in U.S.: A Multinational, Multicenter Early Feasibility Trial of the TiaraTM Transcatheter Mitral Valve

Sep 29, 2014 10:02 am EDT

OPKO Health Supports National Prostate Cancer Council Legislation

Sep 23, 2014 9:17 am EDT

OPKO's Second Rayaldee Phase 3 Trial Meets Primary Endpoints

Sep 11, 2014 9:00 am EDT

Data Supporting Once-Weekly Dosing of hGH-CTP in Growth Hormone Deficient Pediatric Population to be Presented as a Late Breaking Presentation at the European Society of Paediatric Endocrinology Conference

Sep 8, 2014 12:20 pm EDT

OPKO Licensee TESARO Submits New Drug Application for Rolapitant